nodes	percent_of_prediction	percent_of_DWPC	metapath
Pregabalin—CACNA1A—Type II diabetes mellitus—INS-IGF2—polycystic ovary syndrome	0.033	0.119	CbGpPWpGaD
Pregabalin—SLC1A1—endometrium—polycystic ovary syndrome	0.0315	0.0912	CbGeAlD
Pregabalin—SLC1A1—pituitary gland—polycystic ovary syndrome	0.0285	0.0826	CbGeAlD
Pregabalin—SLC1A1—adipose tissue—polycystic ovary syndrome	0.0284	0.0822	CbGeAlD
Pregabalin—Anaemia megaloblastic—Metformin—polycystic ovary syndrome	0.0271	0.0719	CcSEcCtD
Pregabalin—CACNA1A—adrenal gland—polycystic ovary syndrome	0.0261	0.0756	CbGeAlD
Pregabalin—SLC1A1—adrenal gland—polycystic ovary syndrome	0.0255	0.0738	CbGeAlD
Pregabalin—SLC1A1—female gonad—polycystic ovary syndrome	0.0238	0.0688	CbGeAlD
Pregabalin—SLC1A1—vagina—polycystic ovary syndrome	0.0236	0.0684	CbGeAlD
Pregabalin—Abnormal faeces—Metformin—polycystic ovary syndrome	0.0224	0.0592	CcSEcCtD
Pregabalin—SLC1A1—endocrine gland—polycystic ovary syndrome	0.0221	0.064	CbGeAlD
Pregabalin—CACNA2D2—pituitary gland—polycystic ovary syndrome	0.0206	0.0595	CbGeAlD
Pregabalin—CACNA2D2—adrenal gland—polycystic ovary syndrome	0.0184	0.0532	CbGeAlD
Pregabalin—CACNA2D2—vagina—polycystic ovary syndrome	0.017	0.0493	CbGeAlD
Pregabalin—CACNA1A—Type II diabetes mellitus—INSR—polycystic ovary syndrome	0.0167	0.0603	CbGpPWpGaD
Pregabalin—CACNA2D2—endocrine gland—polycystic ovary syndrome	0.0159	0.0461	CbGeAlD
Pregabalin—Tooth abscess—Metformin—polycystic ovary syndrome	0.0153	0.0405	CcSEcCtD
Pregabalin—CACNA2D1—adipose tissue—polycystic ovary syndrome	0.0147	0.0427	CbGeAlD
Pregabalin—CACNA1A—Type II diabetes mellitus—ADIPOQ—polycystic ovary syndrome	0.0139	0.0503	CbGpPWpGaD
Pregabalin—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—DMD—polycystic ovary syndrome	0.0134	0.0484	CbGpPWpGaD
Pregabalin—CACNA2D1—adrenal gland—polycystic ovary syndrome	0.0132	0.0383	CbGeAlD
Pregabalin—CACNA1A—Type II diabetes mellitus—SLC2A4—polycystic ovary syndrome	0.0131	0.0475	CbGpPWpGaD
Pregabalin—CACNA2D1—female gonad—polycystic ovary syndrome	0.0123	0.0357	CbGeAlD
Pregabalin—CACNA2D1—vagina—polycystic ovary syndrome	0.0122	0.0355	CbGeAlD
Pregabalin—Azotaemia—Metformin—polycystic ovary syndrome	0.012	0.0318	CcSEcCtD
Pregabalin—Acidosis—Metformin—polycystic ovary syndrome	0.0115	0.0306	CcSEcCtD
Pregabalin—CACNA2D1—endocrine gland—polycystic ovary syndrome	0.0115	0.0332	CbGeAlD
Pregabalin—Body temperature decreased—Metformin—polycystic ovary syndrome	0.0114	0.0302	CcSEcCtD
Pregabalin—Hypothermia—Metformin—polycystic ovary syndrome	0.0114	0.0302	CcSEcCtD
Pregabalin—Nail disorder—Metformin—polycystic ovary syndrome	0.00986	0.0261	CcSEcCtD
Pregabalin—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—LMNA—polycystic ovary syndrome	0.00919	0.0332	CbGpPWpGaD
Pregabalin—Fungal infection—Metformin—polycystic ovary syndrome	0.00828	0.0219	CcSEcCtD
Pregabalin—CACNA1A—Type II diabetes mellitus—IRS1—polycystic ovary syndrome	0.00772	0.0279	CbGpPWpGaD
Pregabalin—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—TCF7L2—polycystic ovary syndrome	0.00762	0.0275	CbGpPWpGaD
Pregabalin—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—DMD—polycystic ovary syndrome	0.00747	0.027	CbGpPWpGaD
Pregabalin—Chest discomfort—Metformin—polycystic ovary syndrome	0.00723	0.0191	CcSEcCtD
Pregabalin—Accidental injury—Metformin—polycystic ovary syndrome	0.00723	0.0191	CcSEcCtD
Pregabalin—CACNA1A—Calcium Regulation in the Cardiac Cell—ADRA1D—polycystic ovary syndrome	0.00672	0.0243	CbGpPWpGaD
Pregabalin—CACNA1A—Calcium Regulation in the Cardiac Cell—ADRA1B—polycystic ovary syndrome	0.00654	0.0236	CbGpPWpGaD
Pregabalin—Neuropathy—Metformin—polycystic ovary syndrome	0.006	0.0159	CcSEcCtD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.0056	0.0202	CbGpPWpGaD
Pregabalin—Ear pain—Metformin—polycystic ovary syndrome	0.00544	0.0144	CcSEcCtD
Pregabalin—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—LMNA—polycystic ovary syndrome	0.00512	0.0185	CbGpPWpGaD
Pregabalin—Nasal congestion—Metformin—polycystic ovary syndrome	0.0051	0.0135	CcSEcCtD
Pregabalin—Injury—Metformin—polycystic ovary syndrome	0.00505	0.0134	CcSEcCtD
Pregabalin—CACNA1A—Calcium Regulation in the Cardiac Cell—ADRA1A—polycystic ovary syndrome	0.00496	0.0179	CbGpPWpGaD
Pregabalin—Renal impairment—Metformin—polycystic ovary syndrome	0.00488	0.0129	CcSEcCtD
Pregabalin—CACNA1A—Calcium Regulation in the Cardiac Cell—ADRB3—polycystic ovary syndrome	0.00477	0.0172	CbGpPWpGaD
Pregabalin—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00476	0.0126	CcSEcCtD
Pregabalin—Lethargy—Metformin—polycystic ovary syndrome	0.00474	0.0125	CcSEcCtD
Pregabalin—Pain in extremity—Metformin—polycystic ovary syndrome	0.00464	0.0123	CcSEcCtD
Pregabalin—Migraine—Metformin—polycystic ovary syndrome	0.00457	0.0121	CcSEcCtD
Pregabalin—Dehydration—Metformin—polycystic ovary syndrome	0.00432	0.0114	CcSEcCtD
Pregabalin—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00429	0.0113	CcSEcCtD
Pregabalin—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—TCF7L2—polycystic ovary syndrome	0.00425	0.0153	CbGpPWpGaD
Pregabalin—Breast disorder—Metformin—polycystic ovary syndrome	0.00419	0.0111	CcSEcCtD
Pregabalin—Cramp muscle—Metformin—polycystic ovary syndrome	0.00418	0.0111	CcSEcCtD
Pregabalin—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00415	0.011	CcSEcCtD
Pregabalin—CACNA1A—Regulation of insulin secretion—GNAS—polycystic ovary syndrome	0.00405	0.0146	CbGpPWpGaD
Pregabalin—Abdominal distension—Metformin—polycystic ovary syndrome	0.00404	0.0107	CcSEcCtD
Pregabalin—Influenza—Metformin—polycystic ovary syndrome	0.00401	0.0106	CcSEcCtD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00399	0.0144	CbGpPWpGaD
Pregabalin—Pancreatitis—Metformin—polycystic ovary syndrome	0.00393	0.0104	CcSEcCtD
Pregabalin—Angina pectoris—Metformin—polycystic ovary syndrome	0.00391	0.0103	CcSEcCtD
Pregabalin—SLC1A1—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.00375	0.0136	CbGpPWpGaD
Pregabalin—Neutropenia—Metformin—polycystic ovary syndrome	0.00375	0.00993	CcSEcCtD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00361	0.013	CbGpPWpGaD
Pregabalin—Infestation—Metformin—polycystic ovary syndrome	0.00358	0.00947	CcSEcCtD
Pregabalin—Infestation NOS—Metformin—polycystic ovary syndrome	0.00358	0.00947	CcSEcCtD
Pregabalin—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00351	0.00928	CcSEcCtD
Pregabalin—CACNA1A—Calcium Regulation in the Cardiac Cell—CAMK2D—polycystic ovary syndrome	0.00343	0.0124	CbGpPWpGaD
Pregabalin—CACNA2D2—Regulation of insulin secretion—GNAS—polycystic ovary syndrome	0.00339	0.0123	CbGpPWpGaD
Pregabalin—SLC1A1—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00332	0.012	CbGpPWpGaD
Pregabalin—Bradycardia—Metformin—polycystic ovary syndrome	0.00327	0.00866	CcSEcCtD
Pregabalin—Rhinitis—Metformin—polycystic ovary syndrome	0.00322	0.00852	CcSEcCtD
Pregabalin—Hepatitis—Metformin—polycystic ovary syndrome	0.00321	0.0085	CcSEcCtD
Pregabalin—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00319	0.00846	CcSEcCtD
Pregabalin—CACNA1A—Integration of energy metabolism—GNAS—polycystic ovary syndrome	0.00318	0.0115	CbGpPWpGaD
Pregabalin—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00316	0.00838	CcSEcCtD
Pregabalin—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00316	0.00836	CcSEcCtD
Pregabalin—Eye disorder—Metformin—polycystic ovary syndrome	0.003	0.00795	CcSEcCtD
Pregabalin—Flushing—Metformin—polycystic ovary syndrome	0.00298	0.00789	CcSEcCtD
Pregabalin—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00298	0.00789	CcSEcCtD
Pregabalin—Angiopathy—Metformin—polycystic ovary syndrome	0.00291	0.00771	CcSEcCtD
Pregabalin—Immune system disorder—Metformin—polycystic ovary syndrome	0.0029	0.00768	CcSEcCtD
Pregabalin—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00289	0.00766	CcSEcCtD
Pregabalin—Chills—Metformin—polycystic ovary syndrome	0.00288	0.00763	CcSEcCtD
Pregabalin—SLC1A1—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00288	0.0104	CbGpPWpGaD
Pregabalin—Malnutrition—Metformin—polycystic ovary syndrome	0.0028	0.0074	CcSEcCtD
Pregabalin—Flatulence—Metformin—polycystic ovary syndrome	0.00275	0.00729	CcSEcCtD
Pregabalin—Dysgeusia—Metformin—polycystic ovary syndrome	0.00274	0.00725	CcSEcCtD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.00271	0.0098	CbGpPWpGaD
Pregabalin—CACNA1A—Regulation of insulin secretion—INS—polycystic ovary syndrome	0.00271	0.00979	CbGpPWpGaD
Pregabalin—Muscle spasms—Metformin—polycystic ovary syndrome	0.00269	0.00712	CcSEcCtD
Pregabalin—CACNA2D2—Integration of energy metabolism—GNAS—polycystic ovary syndrome	0.00267	0.00964	CbGpPWpGaD
Pregabalin—Vision blurred—Metformin—polycystic ovary syndrome	0.00263	0.00698	CcSEcCtD
Pregabalin—Tremor—Metformin—polycystic ovary syndrome	0.00262	0.00693	CcSEcCtD
Pregabalin—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00259	0.00687	CcSEcCtD
Pregabalin—CACNA1A—Calcium Regulation in the Cardiac Cell—ADRB2—polycystic ovary syndrome	0.00258	0.0093	CbGpPWpGaD
Pregabalin—SLC1A1—Neuronal System—DLG4—polycystic ovary syndrome	0.00254	0.00919	CbGpPWpGaD
Pregabalin—SLC1A1—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	0.00252	0.00911	CbGpPWpGaD
Pregabalin—Malaise—Metformin—polycystic ovary syndrome	0.00252	0.00667	CcSEcCtD
Pregabalin—Syncope—Metformin—polycystic ovary syndrome	0.00251	0.00664	CcSEcCtD
Pregabalin—Palpitations—Metformin—polycystic ovary syndrome	0.00247	0.00654	CcSEcCtD
Pregabalin—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00246	0.00651	CcSEcCtD
Pregabalin—Hypertension—Metformin—polycystic ovary syndrome	0.00241	0.00639	CcSEcCtD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.0024	0.00867	CbGpPWpGaD
Pregabalin—CACNA1A—Calcium Regulation in the Cardiac Cell—GNAS—polycystic ovary syndrome	0.00239	0.00863	CbGpPWpGaD
Pregabalin—Myalgia—Metformin—polycystic ovary syndrome	0.00238	0.0063	CcSEcCtD
Pregabalin—Chest pain—Metformin—polycystic ovary syndrome	0.00238	0.0063	CcSEcCtD
Pregabalin—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00236	0.00626	CcSEcCtD
Pregabalin—Discomfort—Metformin—polycystic ovary syndrome	0.00235	0.00623	CcSEcCtD
Pregabalin—Oedema—Metformin—polycystic ovary syndrome	0.00228	0.00604	CcSEcCtD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.00227	0.00821	CbGpPWpGaD
Pregabalin—CACNA2D2—Regulation of insulin secretion—INS—polycystic ovary syndrome	0.00227	0.00821	CbGpPWpGaD
Pregabalin—Infection—Metformin—polycystic ovary syndrome	0.00227	0.006	CcSEcCtD
Pregabalin—Shock—Metformin—polycystic ovary syndrome	0.00224	0.00594	CcSEcCtD
Pregabalin—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00224	0.00592	CcSEcCtD
Pregabalin—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00223	0.00591	CcSEcCtD
Pregabalin—Skin disorder—Metformin—polycystic ovary syndrome	0.00222	0.00587	CcSEcCtD
Pregabalin—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00221	0.00584	CcSEcCtD
Pregabalin—Anorexia—Metformin—polycystic ovary syndrome	0.00217	0.00576	CcSEcCtD
Pregabalin—CACNA1A—Integration of energy metabolism—INS—polycystic ovary syndrome	0.00213	0.0077	CbGpPWpGaD
Pregabalin—Hypotension—Metformin—polycystic ovary syndrome	0.00213	0.00564	CcSEcCtD
Pregabalin—CACNA1A—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00208	0.00751	CbGpPWpGaD
Pregabalin—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00208	0.0055	CcSEcCtD
Pregabalin—Paraesthesia—Metformin—polycystic ovary syndrome	0.00205	0.00542	CcSEcCtD
Pregabalin—Dyspnoea—Metformin—polycystic ovary syndrome	0.00203	0.00539	CcSEcCtD
Pregabalin—Somnolence—Metformin—polycystic ovary syndrome	0.00203	0.00537	CcSEcCtD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00201	0.00726	CbGpPWpGaD
Pregabalin—Decreased appetite—Metformin—polycystic ovary syndrome	0.00198	0.00525	CcSEcCtD
Pregabalin—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00197	0.00522	CcSEcCtD
Pregabalin—Fatigue—Metformin—polycystic ovary syndrome	0.00197	0.00521	CcSEcCtD
Pregabalin—Constipation—Metformin—polycystic ovary syndrome	0.00195	0.00517	CcSEcCtD
Pregabalin—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00188	0.00498	CcSEcCtD
Pregabalin—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00187	0.00494	CcSEcCtD
Pregabalin—CACNA1A—Neuronal System—DLG4—polycystic ovary syndrome	0.00184	0.00664	CbGpPWpGaD
Pregabalin—Urticaria—Metformin—polycystic ovary syndrome	0.00181	0.0048	CcSEcCtD
Pregabalin—Abdominal pain—Metformin—polycystic ovary syndrome	0.0018	0.00478	CcSEcCtD
Pregabalin—CACNA2D2—Integration of energy metabolism—INS—polycystic ovary syndrome	0.00179	0.00645	CbGpPWpGaD
Pregabalin—CACNA2D2—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00174	0.00629	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—NMNAT3—polycystic ovary syndrome	0.00169	0.00611	CbGpPWpGaD
Pregabalin—Asthenia—Metformin—polycystic ovary syndrome	0.00164	0.00433	CcSEcCtD
Pregabalin—Pruritus—Metformin—polycystic ovary syndrome	0.00161	0.00427	CcSEcCtD
Pregabalin—Diarrhoea—Metformin—polycystic ovary syndrome	0.00156	0.00413	CcSEcCtD
Pregabalin—CACNA1A—Metabolism—LPCAT2—polycystic ovary syndrome	0.00155	0.00559	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—SUOX—polycystic ovary syndrome	0.00155	0.00559	CbGpPWpGaD
Pregabalin—CACNA2D2—Neuronal System—DLG4—polycystic ovary syndrome	0.00154	0.00557	CbGpPWpGaD
Pregabalin—Dizziness—Metformin—polycystic ovary syndrome	0.00151	0.00399	CcSEcCtD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.00151	0.00544	CbGpPWpGaD
Pregabalin—Vomiting—Metformin—polycystic ovary syndrome	0.00145	0.00384	CcSEcCtD
Pregabalin—Rash—Metformin—polycystic ovary syndrome	0.00144	0.00381	CcSEcCtD
Pregabalin—CACNA1A—Metabolism—ISYNA1—polycystic ovary syndrome	0.00144	0.00519	CbGpPWpGaD
Pregabalin—Dermatitis—Metformin—polycystic ovary syndrome	0.00144	0.00381	CcSEcCtD
Pregabalin—Headache—Metformin—polycystic ovary syndrome	0.00143	0.00378	CcSEcCtD
Pregabalin—CACNA2D2—Metabolism—NMNAT3—polycystic ovary syndrome	0.00142	0.00512	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.0014	0.00506	CbGpPWpGaD
Pregabalin—Nausea—Metformin—polycystic ovary syndrome	0.00136	0.00359	CcSEcCtD
Pregabalin—CACNA2D2—Metabolism—SUOX—polycystic ovary syndrome	0.0013	0.00468	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—LPCAT2—polycystic ovary syndrome	0.0013	0.00468	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.00128	0.00463	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—TEAD2—polycystic ovary syndrome	0.00122	0.00442	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—AKR1C2—polycystic ovary syndrome	0.00122	0.00442	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—ISYNA1—polycystic ovary syndrome	0.00121	0.00435	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.00108	0.00388	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—TEAD2—polycystic ovary syndrome	0.00102	0.0037	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—AKR1C2—polycystic ovary syndrome	0.00102	0.0037	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—PNPLA2—polycystic ovary syndrome	0.00102	0.0037	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—SRD5A1—polycystic ovary syndrome	0.000972	0.00351	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—STAR—polycystic ovary syndrome	0.000927	0.00335	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000859	0.0031	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—HMMR—polycystic ovary syndrome	0.000826	0.00298	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000814	0.00294	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—HSD3B1—polycystic ovary syndrome	0.000788	0.00285	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—STAR—polycystic ovary syndrome	0.000777	0.0028	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—LHB—polycystic ovary syndrome	0.000719	0.0026	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—HSD3B2—polycystic ovary syndrome	0.000702	0.00254	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—HMMR—polycystic ovary syndrome	0.000692	0.0025	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—AKR1C1—polycystic ovary syndrome	0.00068	0.00246	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—HSD3B1—polycystic ovary syndrome	0.00066	0.00238	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—SULT2A1—polycystic ovary syndrome	0.000626	0.00226	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—RRM2—polycystic ovary syndrome	0.000606	0.00219	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—LHB—polycystic ovary syndrome	0.000602	0.00217	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—HSD3B2—polycystic ovary syndrome	0.000589	0.00213	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—YAP1—polycystic ovary syndrome	0.000584	0.00211	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—AKR1C1—polycystic ovary syndrome	0.00057	0.00206	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—NAMPT—polycystic ovary syndrome	0.000562	0.00203	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—CYP11A1—polycystic ovary syndrome	0.000555	0.002	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—SULT2A1—polycystic ovary syndrome	0.000525	0.00189	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—AKR1C3—polycystic ovary syndrome	0.000524	0.00189	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—CYP17A1—polycystic ovary syndrome	0.000516	0.00186	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—RRM2—polycystic ovary syndrome	0.000508	0.00183	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—YAP1—polycystic ovary syndrome	0.00049	0.00177	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—NAMPT—polycystic ovary syndrome	0.000471	0.0017	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—CYP11A1—polycystic ovary syndrome	0.000465	0.00168	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—TH—polycystic ovary syndrome	0.000446	0.00161	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—AKR1C3—polycystic ovary syndrome	0.000439	0.00158	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—SLC2A4—polycystic ovary syndrome	0.000434	0.00157	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—CYP17A1—polycystic ovary syndrome	0.000432	0.00156	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—CYP19A1—polycystic ovary syndrome	0.000408	0.00147	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—TH—polycystic ovary syndrome	0.000374	0.00135	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—GNAS—polycystic ovary syndrome	0.000364	0.00132	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—SLC2A4—polycystic ovary syndrome	0.000364	0.00131	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—NCOR1—polycystic ovary syndrome	0.000347	0.00125	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—CYP19A1—polycystic ovary syndrome	0.000342	0.00123	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—CYP1A1—polycystic ovary syndrome	0.000329	0.00119	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—MTHFR—polycystic ovary syndrome	0.000307	0.00111	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—GNAS—polycystic ovary syndrome	0.000305	0.0011	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—NCOR1—polycystic ovary syndrome	0.000291	0.00105	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—CYP1A1—polycystic ovary syndrome	0.000276	0.000995	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—MTHFR—polycystic ovary syndrome	0.000257	0.000928	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—PPARG—polycystic ovary syndrome	0.000249	0.000898	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—POMC—polycystic ovary syndrome	0.000245	0.000886	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—INS—polycystic ovary syndrome	0.000244	0.000881	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PPARG—polycystic ovary syndrome	0.000208	0.000752	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—POMC—polycystic ovary syndrome	0.000205	0.000742	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—INS—polycystic ovary syndrome	0.000204	0.000738	CbGpPWpGaD
